Structural and functional features of the HIV envelope glycoprotein and considerations for vaccine development.
Putney
S D
SD
Rusche
J
J
Javaherian
K
K
Matthews
T
T
Bolognesi
D
D
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D000595:Amino Acid Sequence; D015704:CD4 Antigens / Q000378:metabolism; D000939:Epitopes / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000276:immunology*; D015700:HIV Envelope Protein gp41 / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D008561:Membrane Fusion; D008969:Molecular Sequence Data; D013601:T-Lymphocytes / Q000276:immunology; D014765:Viral Vaccines
D015704:CD4 Antigens; D000939:Epitopes; D015699:HIV Envelope Protein gp120; D015700:HIV Envelope Protein gp41; D014765:Viral Vaccines